MLchartDataset catalogue

TLR7 agonist SHR2150

Term · Oncology and biomedicine · MLC-T-ONC-017205

A Toll-like receptor (TLR) 7 agonist with potential immunostimulating and antineoplastic activities. Upon administration, TLR7 agonist SHR2150 targets, binds to and activates TLR7. This may trigger, in addition to other possible responses, the activation of dendritic cells (DCs), macrophages and B cells, and activate cluster of differentiation (CD) 8+ T cells. This may induce anti-tumor immune responses. TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.

Table 1. Record
IdentifierMLC-T-ONC-017205
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017205",
  "term": "TLR7 agonist SHR2150",
  "field": "Oncology and biomedicine",
  "definition": "A Toll-like receptor (TLR) 7 agonist with potential immunostimulating and antineoplastic activities. Upon administration, TLR7 agonist SHR2150 targets, binds to and activates TLR7. This may trigger, in addition to other possible responses, the activation of dendritic cells (DCs), macrophages and B cells, and activate cluster of differentiation (CD) 8+ T cells. This may induce anti-tumor immune responses. TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tlr7-agonist-shr2150/"
}

Record 16,429 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.